Allogene Therapeutics Inc (ALLO)
Retained Earnings
-$2.10B
Quarterly · Period ending: · USD
ALLO Retained Earnings
Latest reported-$2.10Bperiod ending
Latest reported-$2.10Bperiod ending
ALLO Quarterly Retained Earnings (-$137.52M → -$2.10B)
Quarterly retained earnings
High-resolution chart · PNG
ALLO retained earnings history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Retained Earnings (USD) |
|---|---|
| -2,095,993,000 | |
| -2,053,315,999 | |
| -2,010,709,000 | |
| -1,971,899,000 | |
| -1,930,499,000 | |
| -1,879,556,000 | |
| -1,819,823,000 | |
| -1,759,884,000 | |
| -1,693,591,000 | |
| -1,627,233,000 | |
| -1,562,233,000 | |
| -1,473,988,000 | |
| -1,412,673,000 | |
| -1,334,684,000 | |
| -1,234,968,000 | |
| -1,141,133,000 | |
| -1,057,985,000 | |
| -983,198,000 | |
| -894,554,000 | |
| -828,480,000 | |
| -750,294,000 | |
| -679,358,000 | |
| -646,343,000 | |
| -577,773,000 | |
| -511,576,000 | |
| -450,602,000 | |
| -396,122,000 | |
| -335,092,000 | |
| -284,357,000 | |
| -243,114,000 | |
| -211,528,000 | |
| -181,019,000 | |
| -137,522,000 |